Profile

Cover photo
24 followers|12,700 views
AboutPostsPhotosVideos

Stream

Westwicke Partners

Shared publicly  - 
 
Your relationship with your IR advisor is like any other: You get more out of it by putting more into it. Here are some do’s and don’ts. http://bit.ly/2djjqPp
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Check out our latest eBook, Westwicke Partners Insider’s Guide to Investor Relations. You won’t find a more thorough guide to the IR process for healthcare executives anywhere.
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Here’s our guidance on how often you should update your IR presentation deck, and who should be involved in the process. http://bit.ly/2bxpznm
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Here’s how to expand the number of sell-side analysts covering your company. The first step is to know that it’s a process. http://bit.ly/2aNmHVR
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Investors bearish on biotech despite 2016’s median pre-money IPO valuation being 30 percent higher than the ‘13–‘14 boom: http://bit.ly/2a3PK8e
After five very strong years, biotech as a sector has struggled to catalyze positive investor sentiment so far for the past 12 months. In a disastrous start to the year, the NASDAQ Biotech Index shed 30% in just the first 40 days. The carnage of this winter’s market was captured [...]
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Need an investment bank? You’ll likely be presented plenty of so-called league tables. But to find the right bank for you, you’ll want to go deeper. Here are five factors to consider. http://bit.ly/29ibjfH
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
The crucial J.P. Morgan Healthcare Conference is coming faster than you think. You need to start preparing now. Here’s what to do.
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Earnings calls are no fun for anyone – and they’re not supposed to be. Still, these three ideas could make them more compelling, or at least easier to prepare for.
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
If market conditions force a delay in your planned IPO, you might as well make the most of the extra time. Here are five ideas for doing that. http://bit.ly/2bfDHpt
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
You may have heard that the SEC has issued new guidance on regulations governing the reporting of non-GAAP financial measures. It’s important you understand the rules, so we have a detailed explanation. http://bit.ly/29Ut0sd
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Management credibility is essential if you’re going to have a positive relationship with your investors. So you how do you build yours? Start here. http://bit.ly/29Oy6UH
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Product differentiation, among other challenges, will be tricky for startups with all eyes on the same cancer-immunotherapy prize in this I/O gold rush. What do you think? http://bit.ly/29ezBa9
With the big cancer confab ASCO 2016 fading into memory, R&D teams everywhere are getting back to work on their cancer programs – and across the industry many of them will be doing the same work, on the same targets,
1
Add a comment...
Story
Tagline
Strategic Investor Relations and Independent Capital Markets Advice
Introduction
Westwicke Partners provides customized investor relations programs and independent capital markets advice to both public and private healthcare companies.
Contact Information
Contact info
Phone
(443) 213-0500
Email